BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:40 PM
 | 
Sep 24, 2009
 |  BC Extra  |  Company News

FDA panel backs reformulated OxyContin

A joint FDA panel voted 14-4, with one abstention, to recommend approval of an NDA from Purdue Pharma L.P. (Stamford, Conn.) for a reformulated version of controlled-release OxyContin oxycodone to manage moderate to severe pain. The members of FDA's Anesthetic and Life Support...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >